{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:02:55Z","timestamp":1793084575642,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100019004","name":"Deanship of Research, Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["20220257"],"award-info":[{"award-number":["20220257"]}],"id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with chronic kidney disease (CKD) often experience a poor quality of life (QoL), prolonged hospital stays (length of stay, LOS), and an increased risk of drug-related problems (DRPs) due to high comorbidity rates, pill burden, and frequent care transitions. Providing effective management can significantly improve the overall health status of CKD patients. This study evaluated the impact of the pharmacist-led medication reconciliation service on health-related QoL and LOS in CKD inpatients and the prevalence of DRPs in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This 9-month prospective quasi-experimental study was conducted on hospitalized patients with CKD in two phases: a control period and an intervention period. Control phase care followed usual hospital practice. In the intervention phase, the pharmacist carried out reconciliation and review of medications over the stay. Patients\u2019 data were collected from hospital records and patient interviews. Detected drug-related problems (DRPs) were discussed with the physicians. Participants were followed for 1 month after discharge to measure QoL, using the EQ-5D-5L (European Quality of Life 5 Dimensions 5 Level Version) questionnaire. Predictors of high DRP burden were analyzed via logistic regression. Multivariable quantile regression was applied to explore factors influencing LOS and QoL at discharge and at the 1-month follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the study sample (212), 142 (67%) and 70 (33%) participants were enrolled during the intervention and control periods, respectively. A mean of 7.05 (SD = 3.41) DRPs per CKD patient was recognized. Discrepancies and inappropriate medication and dosage selection were the most prevalent DRPs. Compared with the control, utility values (QoL) were higher in the intervention group at discharge (0.17 increase; 95% confidence interval [CI] = 0.048\u20130.298) and at follow-up (0.24 increase; 95%CI = 0.09\u20130.39). The intervention group had a shorter LOS by 2.43\u2009days than the control group (95% CI = \u20134.49 to \u20130.37; P\u2009=\u2009.021).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The pharmacist-led supplemented medication reconciliation demonstrated positive effects on QoL and LOS among CKD patients. These results support the integration of clinical pharmacy services into interdisciplinary healthcare for CKD management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/intqhc\/mzaf132","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:53:39Z","timestamp":1766494419000},"source":"Crossref","is-referenced-by-count":1,"title":["The impact of pharmacist-led medication reconciliation on quality of life and hospital stay in chronic kidney disease: a prospective study in Jordan"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-600X","authenticated-orcid":false,"given":"Nahlah M","family":"Sallam","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology , Irbid,","place":["Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8345-4048","authenticated-orcid":false,"given":"Shoroq M","family":"Altawalbeh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology , Irbid,","place":["Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2466-4763","authenticated-orcid":false,"given":"Osama Y","family":"Alshogran","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology , Irbid,","place":["Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"2026031715134043200_mzaf132-B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001570","article-title":"A systematic review of evidence on the links between patient experience and clinical safety and effectiveness","volume":"3","author":"Doyle","year":"2013","journal-title":"BMJ Open"},{"key":"2026031715134043200_mzaf132-B2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59101788","article-title":"Assessment of health-related quality of life in chronic kidney disease patients: a hospital-based cross-sectional study","volume":"59","author":"Sharma","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"2026031715134043200_mzaf132-B3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12955-021-01905-7","article-title":"Predictors of poor health-related quality of life among hemodialysis patients with anemia in Jordan","volume":"19","author":"Alshogran","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"2026031715134043200_mzaf132-B4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026031715134043200_mzaf132-B5","doi-asserted-by":"publisher","first-page":"e051888","DOI":"10.1136\/bmjopen-2021-051888","article-title":"Healthcare resource utilisation for chronic kidney disease and other major non-communicable chronic diseases in China: a cross-sectional study","volume":"12","author":"Yang","year":"2022","journal-title":"BMJ Open"},{"key":"2026031715134043200_mzaf132-B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/hex.12619","article-title":"Impact and experiences of delayed discharge: a mixed-studies systematic review","volume":"21","author":"Rojas-Garcia","year":"2018","journal-title":"Health Expect"},{"key":"2026031715134043200_mzaf132-B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/intqhc\/mzab160","article-title":"Evaluation of the association of length of stay in hospital and outcomes","volume":"34","author":"Han","year":"2022","journal-title":"Int J Qual Health Care"},{"key":"2026031715134043200_mzaf132-B8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1186\/s12877-023-04557-y","article-title":"Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Geriatr"},{"key":"2026031715134043200_mzaf132-B9","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s11096-013-9806-8","article-title":"Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan","volume":"35","author":"AbuRuz","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"2026031715134043200_mzaf132-B10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s11096-021-01259-6","article-title":"Treatment related problems in Jordanian hemodialysis patients","volume":"43","author":"Shqeirat","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"2026031715134043200_mzaf132-B11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/17425255.2014.931371","article-title":"Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis","volume":"10","author":"Velenosi","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2026031715134043200_mzaf132-B12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4212\/cjhp.v62i5.826","article-title":"Best possible medication history for hemodialysis patients obtained by a pharmacy technician","volume":"62","author":"Leung","year":"2009","journal-title":"Can J Hosp Pharm"},{"key":"2026031715134043200_mzaf132-B13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ekir.2019.10.008","article-title":"The relationship between medication discrepancies and hospitalization risk among patients with advanced CKD","volume":"5","author":"Sakhiya","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026031715134043200_mzaf132-B14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11096-019-00816-4","article-title":"Clinical pharmacy practice in the care of chronic kidney disease patients: a systematic review","volume":"41","author":"Al Raiisi","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"2026031715134043200_mzaf132-B15","year":"2017"},{"key":"2026031715134043200_mzaf132-B16","year":"2019"},{"key":"2026031715134043200_mzaf132-B17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"2026031715134043200_mzaf132-B18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026031715134043200_mzaf132-B19","first-page":"16","article-title":"Validity and reliability of the Arabic version of the the EuroQOL (EQ-5D): a study from Saudi Arabia","volume":"12","author":"Bekairy","year":"2018","journal-title":"Int J Health Sci (Qassim)"},{"key":"2026031715134043200_mzaf132-B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13104-019-4067-9","article-title":"Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results","volume":"12","author":"Gerlinger","year":"2019","journal-title":"BMC Res Notes"},{"key":"2026031715134043200_mzaf132-B21","author":"Pharmaceutical Care Network Europe","year":"2020"},{"key":"2026031715134043200_mzaf132-B22","doi-asserted-by":"publisher","first-page":"2488173","DOI":"10.1080\/20523211.2025.2488173","article-title":"The impact of medication reconciliation on discrepancies and all-cause readmission among hospitalised patients with chronic kidney disease: a quasi-experimental study","volume":"18","author":"Altawalbeh","year":"2025","journal-title":"J Pharm Policy Pract"},{"key":"2026031715134043200_mzaf132-B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10081788","article-title":"Effectiveness of clinical pharmacist service on drug-related problems and patient outcomes for hospitalized patients with chronic kidney disease: a randomized controlled trial","volume":"10","author":"Song","year":"2021","journal-title":"J Clin Med"},{"key":"2026031715134043200_mzaf132-B24","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s11096-022-01453-0","article-title":"The role of clinical pharmacist in enhancing hemodialysis patients\u2019 adherence and clinical outcomes: a randomized-controlled study","volume":"44","author":"Alshogran","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"2026031715134043200_mzaf132-B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191811170","article-title":"The effectiveness of pharmacist interventions in the management of patient with renal failure: a systematic review and Meta-Analysis","volume":"19","author":"Jasinska-Stroschein","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026031715134043200_mzaf132-B26","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.4103\/1319-2442.220879","article-title":"Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients\u2014a multicenter randomized controlled study","volume":"28","author":"Mateti","year":"2017","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2026031715134043200_mzaf132-B27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1542-4758.2009.00328.x","article-title":"Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2-year randomized, controlled study","volume":"13","author":"Pai","year":"2009","journal-title":"Hemodial Int"},{"key":"2026031715134043200_mzaf132-B28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4103\/1319-2442.109566","article-title":"Predictors of quality of life in hemodialysis patients","volume":"24","author":"Bayoumi","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2026031715134043200_mzaf132-B29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3109\/00365548.2013.827338","article-title":"Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit","volume":"45","author":"Jiang","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"2026031715134043200_mzaf132-B30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s11096-017-0528-1","article-title":"Outcomes of pharmacist-provided medication review in collaborative care for adult Singaporeans receiving hemodialysis","volume":"39","author":"Chia","year":"2017","journal-title":"Int J Clin Pharm"}],"container-title":["International Journal for Quality in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/intqhc\/advance-article-pdf\/doi\/10.1093\/intqhc\/mzaf132\/66125459\/mzaf132.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intqhc\/article-pdf\/38\/1\/mzaf132\/66125459\/mzaf132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intqhc\/article-pdf\/38\/1\/mzaf132\/66125459\/mzaf132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T19:13:47Z","timestamp":1773774827000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intqhc\/article\/doi\/10.1093\/intqhc\/mzaf132\/8404410"}},"subtitle":[],"editor":[{"given":"Linda","family":"Graudins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,10]]}},"URL":"https:\/\/doi.org\/10.1093\/intqhc\/mzaf132","relation":{},"ISSN":["1353-4505","1464-3677"],"issn-type":[{"value":"1353-4505","type":"print"},{"value":"1464-3677","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,24]]},"article-number":"mzaf132"}}